The store will not work correctly when cookies are disabled.
Biological Data
|
Biological description
|
Wnt/β-catenin inhibitor and PPARγ/δ antagonist. Reduces NO production. Shows antiproliferative and anti-cancer actions. |
Solubility & Handling
|
Storage instructions
|
+4°C |
|
Solubility overview
|
Soluble in DMSO (75mM) |
|
Important
|
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use. |
Chemical Data
|
Chemical name
|
2,5-Dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide |
|
Chemical structure
|
![FH 535 [108409-83-2] Chemical Structure](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR4nGP6zwAAAgcBApocMXEAAAAASUVORK5CYII= "FH 535 [108409-83-2]")
|
|
Molecular Formula
|
C13H10Cl2N2O4S |
|
PubChem identifier
|
3463933 |
|
SMILES
|
ClC1=CC(S(NC2=C(C)C=C([N+]([O-])=O)C=C2)(=O)=O)=C(Cl)C=C1 |
|
InChiKey
|
AXNUEXXEQGQWPA-UHFFFAOYSA-N |
References for FH 535
References are publications that support the biological activity of the product
-
FH535 inhibits the proliferation of HepG2 cells via downregulation of the Wnt/β-catenin signaling pathway.
Liu J et al (2014)
Mol Med Rep 9(4) : 1289-92.
-
Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535.
Gedaly R et al (2014)
PLoS One 9(6) : e99272.
-
A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.
Handeli S et al (2008)
Mol Cancer Ther 7(3) : 521-9.
Wnt/β-catenin inhibitor and PPARγ/δ antagonist.
![FH 535 [108409-83-2] Chemical Structure](https://m2stage-v2.hellobio.com/media/catalog/product//h/b/hb0288.png "FH 535 [108409-83-2]")
Understanding purity and quality - a guide for life scientists